VEGFR-1 Expression Relates to Fuhrman Nuclear Grade ofClear Cell Renal Cell Carcinoma
Authors:
Open Access
- 31 March 2014
- journal article
- Published by Institute of Lifestyle Medicine in Journal of Lifestyle Medicine
- Vol. 4 (1) , 64-70
Abstract
Increasing evidence suggests that vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) 1 signaling may play an important role in the progression of pathological angiogenesis that occurs in many tumors, including renal cell carcinoma (RCC). Therapeutic targeting directed against VEGF and VEGFR-2 has been proven to be successful for metastatic clear cell RCC (CCRCC). However, the expression of VEGFR-1 and its association with prognostic parameters of CCRCC in the tumorigenesis of renal cancer remains unclear. Therefore, we examined the expression of VEGFR-1 and its prognostic significance in CCRCC. Immunohistochemical staining for VEGFR-1 was performed on 126 formalin-fixed paraffin-embedded CCRCC tissue samples. Six of these cases were available for Western blot analyses. The results were compared with various clinicopathologic parameters of CCRCC and patients' survival. VEGFR-1 expression was detected in 59 cases (46.8%) of CCRCC. Higher VEGFR-1 expression was significantly correlated with a lower Fuhrman nuclear grade and the absence of renal pelvis invasion, although it was not related to patients' survival. Western blot analyses showed higher VEGFR-1 expression in low grade tumors. VEGFR-1 expression may be associated with favorable prognostic factors, particularly a lower Fuhrman nuclear grade in CCRCC.Keywords
This publication has 24 references indexed in Scilit:
- Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010Cancer Research and Treatment, 2013
- Current Status of Targeted Therapy for Advanced Renal Cell CarcinomaKorean Journal of Urology, 2012
- Global increases in kidney cancer incidence, 1973–1992European Journal Of Cancer Prevention, 2002
- The von Hippel–Lindau Tumor Suppressor GeneExperimental Cell Research, 2001
- Role of transforming growth factor-alpha in von Hippel- Lindau (VHL)-/- clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesisProceedings of the National Academy of Sciences, 2001
- Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.Proceedings of the National Academy of Sciences, 1996
- Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.Proceedings of the National Academy of Sciences, 1996
- Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells.Proceedings of the National Academy of Sciences, 1995
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells.Journal of Clinical Investigation, 1990